The influence of radiotherapy on cardiac disorders;Wpływ radioterapii na zaburzenia pracy serca

Wspolczesna Onkologia

Volumn 13, Issue 1, 2009, Pages 16-21

  Ziółkowska, Ewa ^a   Woźniak Wiśniewska, Anita ^b,c,d   Wiśniewski, Tomasz ^a,c,d   Makarewicz, Roman ^c   Sinkiewicz, Władysław ^b,c,d  

^a Centrum Onkologii im prof F Lukaszczyka w Bydgoszcz   (Poland)

^b Antoni Jurasz University Hospital   (Poland)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cardiac toxicity; Radiation induced heart disease; Radiotherapy

Indexed keywords

CARDIOTOXIN; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN; MITOXANTRONE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; HEART DISEASE; HEART MUSCLE; HEART VALVE; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; REVIEW;

EID: 66449093701     PISSN: 14282526     EISSN: 14282526     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol 2005; 17: 153-159.
2. Lund MB, Ihlen H, Voss BM, Abrahamsen AF, Nome O, Kongerud J, Stugaard M, Forfang K. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart 1996; 75: 591-5.
3. Steele GG. Basic clinical radiobiology. 2nd ed. Arnold Press, London 1997; 30-9.
4. Constine LS, Schwartz RG, Savage DE, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997; 39: 897-906.
5. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol 2003; 42: 743-9.
6. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003; 290: 2831-7.
7. Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications. Cancer 1976; 37: 2813-25.
8. Martí V, García J, Augé JM, Obrador D, Ballester M. Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. Chest 1991; 100: 1180-2.
9. Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15-29.
10. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ 2003; 326: 256-7.
11. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557-65.
12. Yu X, Prosnitz RR, Zhou S, et al. Symptomatic cardiac events following radiation therapy for left-sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. Clin Breast Cancer 2003; 4: 93-197.
13. Lind PA, Pagnanelli R, Marks LB, Borges-Neto S, Hu C, Zhou SM, Light K, Hardenbergh PH. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 2003; 55: 914-20.
14. Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys 1996; 36: 899-905.
15. Hardenbergh PH, Munley MT, Bentel GC, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001; 49: 1023-8.
16. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995; 31: 1205-11.
17. Jurado J, Thompson PD. Prevention of coronary artery disease in cancer patients. Pediatr Blood Cancer 2005; 44: 620-4.
18. Gillette EL, McChesney SL, Hoopes PJ. Isoeffect curves for radiation induced cardiomyopathy in the dog. Int J Radiat Oncol Biol Phys 1985; 11: 2091-7.
19. Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast cancer radiotherapy: 1950-1990s. Int J Radiat Oncol Biol Phys 2007; 69: 1484-95.
20. Lagrange J, Darcourt J, Benoliel J, Bensadoun R, Migneco O. Acute cardiac effects of mediastinal irradiation: assessment by radionuclide angiography. Int J Radiat Oncol Biol Phys 1992; 22: 897-903.
21. Ikaheimo MJ, Niemela KO, Linnaluoto MM, Jakobsson MJT, Takkunen JT, Taskinen PJ. Early cardiac changes related to radiation therapy. Am J Cardiol 1985; 56: 943-6.
22. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. Radiation associated cardiovascular disease. Crit Rev Oncol Hematol 2003; 45: 55-75.
23. Orzan F, Brusca A, Gaita F, Giustetto C, Figliomeni MC, Libero L. Associated cardiac lesions in patients with radiation induced complete heart block. Int J Cardiol 1993; 39: 151-6.
24. Vallis KA, Pintilie M, Chong N, Holowaty E, Douglas PS, Kirkbride P, Wielgosz A. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol 2002; 20: 1036-42.
25. Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, Prosnitz LR, Marks LB. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001; 49: 1023-8.
26. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993; 11: 1208-15.
27. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998; 16: 2625-31.
28. Taylor CW, McGale P, Darby SC. Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol (R Coll Radiol) 2006; 18: 236-46.
29. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003; 160: 381-407.
30. Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950e1990. Radiat Res 1999; 152: 374-89.
31. Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 2003; 21: 1513-23.
32. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69: 1241-7.
33. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270: 1949-55.
34. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000; 355: 1757-70.
35. Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, Darby SC. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 2008; 72: 501-7.
36. Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 302-14.
37. Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 1990; 4: 3076-86.
38. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996; 125: 47-58.
39. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-7.
40. Shankar SM, Marina N, Hudson MM, et al.; Cardiovascular Disease Task Force of the Children's Oncology Group. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics 2008; 121: 387-96.
41. de Graaf H, Dolsma WV, Willemse PH, van der Graaf WT, Sleijfer DT, de Vries EG, Mulder NH. Cardiotoxicity from intensive chemotherapycombined with radiotherapy in breast cancer. Br J Cancer 1997; 76: 943-5.
42. Shapiro CL, Hardenbergh PH, Gelman R, et al. Cardiac effects of adjuvant doxorubicin in radiation therapy in breast cancer patients. J Clin Oncol 1998; 16: 3493-501.
43. Theodoulou M, Seidman AD. Cardiac effects of adjuvant therapy for early breast cancer. Semin Oncol 2003; 30: 730-9.
44. Szmit S, Opolski G, Szczylik C. Powikłania kardiologiczne jako powiklania terapii celowanych. Współcz Onkol 2008; 12: 318-23.
45. Perez EA, Rodeheffer R. Clinical cardiac tolerability of trastuzumab. J Clin Oncol 2004; 22: 322-9.
46. Gyenes G, Gagliardi G, Lax I, Fornander T, Rutqvist LE. Evaluation of irradiated heart volumes in Stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 1997; 15: 1348-53.